Treatment of febrile episodes in neutropenic patients.
D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D005334:Fever / Q000188:drug therapy*; D006801:Humans; D007165:Immunosuppression Therapy; D007239:Infections / Q000188:drug therapy*; D007938:Leukemia / Q000150:complications; D009503:Neutropenia / Q000150:complications*; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000627:therapeutic use; D014031:Tobramycin / Q000008:administration & dosage / Q000627:therapeutic use*; D014295:Trimethoprim / Q000008:administration & dosage / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D002981:Clindamycin; D014295:Trimethoprim; D013420:Sulfamethoxazole; D014031:Tobramycin